BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34140493)

  • 21. Fyn and Lck tyrosine kinases regulate tyrosine phosphorylation of p105CasL, a member of the p130Cas docking protein family, in T-cell receptor-mediated signalling.
    Kanda H; Mimura T; Hamasaki K; Yamamoto K; Yazaki Y; Hirai H; Nojima Y
    Immunology; 1999 May; 97(1):56-61. PubMed ID: 10447714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TCR signals mediated by Src family kinases are essential for the survival of naive T cells.
    Seddon B; Zamoyska R
    J Immunol; 2002 Sep; 169(6):2997-3005. PubMed ID: 12218114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T cells infiltrating non-Hodgkin's B cell lymphomas show altered tyrosine phosphorylation pattern even though T cell receptor/CD3-associated kinases are present.
    Wang Q; Stanley J; Kudoh S; Myles J; Kolenko V; Yi T; Tubbs R; Bukowski R; Finke J
    J Immunol; 1995 Aug; 155(3):1382-92. PubMed ID: 7636203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma.
    Boddicker RL; Razidlo GL; Dasari S; Zeng Y; Hu G; Knudson RA; Greipp PT; Davila JI; Johnson SH; Porcher JC; Smadbeck JB; Eckloff BW; Billadeau DD; Kurtin PJ; McNiven MA; Link BK; Ansell SM; Cerhan JR; Asmann YW; Vasmatzis G; Feldman AL
    Blood; 2016 Sep; 128(9):1234-45. PubMed ID: 27297792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid T-cell receptor-mediated tyrosine phosphorylation of p120, an Fyn/Lck Src homology 3 domain-binding protein.
    Reedquist KA; Fukazawa T; Druker B; Panchamoorthy G; Shoelson SE; Band H
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4135-9. PubMed ID: 7514295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roles of the Src tyrosine kinases Lck and Fyn in regulating gammadeltaTCR signal strength.
    Laird RM; Hayes SM
    PLoS One; 2010 Jan; 5(1):e8899. PubMed ID: 20126650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Novel, LAT/Lck Double Deficient T Cell Subline J.CaM1.7 for Combined Analysis of Early TCR Signaling.
    Vico-Barranco I; Arbulo-Echevarria MM; Serrano-García I; Pérez-Linaza A; Miranda-Sayago JM; Miazek A; Narbona-Sánchez I; Aguado E
    Cells; 2021 Feb; 10(2):. PubMed ID: 33562083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
    Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
    Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feedback circuits monitor and adjust basal Lck-dependent events in T cell receptor signaling.
    Schoenborn JR; Tan YX; Zhang C; Shokat KM; Weiss A
    Sci Signal; 2011 Sep; 4(190):ra59. PubMed ID: 21917715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD28-CAR-T cell activation through FYN kinase signaling rather than LCK enhances therapeutic performance.
    Wu L; Brzostek J; Sakthi Vale PD; Wei Q; Koh CKT; Ong JXH; Wu LZ; Tan JC; Chua YL; Yap J; Song Y; Tan VJY; Tan TYY; Lai J; MacAry PA; Gascoigne NRJ
    Cell Rep Med; 2023 Feb; 4(2):100917. PubMed ID: 36696897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The distinct capacity of Fyn and Lck to phosphorylate Sam68 in T cells is essentially governed by SH3/SH2-catalytic domain linker interactions.
    Feuillet V; Semichon M; Restouin A; Harriague J; Janzen J; Magee A; Collette Y; Bismuth G
    Oncogene; 2002 Oct; 21(47):7205-13. PubMed ID: 12370810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Separate signaling events control TCR downregulation and T cell activation in primary human T cells.
    van der Donk LEH; Ates LS; van der Spek J; Tukker LM; Geijtenbeek TBH; van Heijst JWJ
    Immun Inflamm Dis; 2021 Mar; 9(1):223-238. PubMed ID: 33350598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma.
    Streubel B; Vinatzer U; Willheim M; Raderer M; Chott A
    Leukemia; 2006 Feb; 20(2):313-8. PubMed ID: 16341044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arsenic interferes with the signaling transduction pathway of T cell receptor activation by increasing basal and induced phosphorylation of Lck and Fyn in spleen cells.
    Soto-Peña GA; Vega L
    Toxicol Appl Pharmacol; 2008 Jul; 230(2):216-26. PubMed ID: 18407307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrinsic properties and plasma membrane trafficking route of Src family kinase SH4 domains sensitive to retargeting by HIV-1 Nef.
    Chase AJ; Wombacher R; Fackler OT
    J Biol Chem; 2018 May; 293(20):7824-7840. PubMed ID: 29588370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma.
    Pechloff K; Holch J; Ferch U; Schweneker M; Brunner K; Kremer M; Sparwasser T; Quintanilla-Martinez L; Zimber-Strobl U; Streubel B; Gewies A; Peschel C; Ruland J
    J Exp Med; 2010 May; 207(5):1031-44. PubMed ID: 20439541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic evidence of a role for Lck in T-cell receptor function independent or downstream of ZAP-70/Syk protein tyrosine kinases.
    Wong J; Straus D; Chan AC
    Mol Cell Biol; 1998 May; 18(5):2855-66. PubMed ID: 9566904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular understanding of peripheral T-cell lymphomas, not otherwise specified (PTCL, NOS): A complex disease category.
    Sakata-Yanagimoto M; Fukumoto K; Karube K; Chiba S
    J Clin Exp Hematop; 2021 Jun; 61(2):61-70. PubMed ID: 33716242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphoproteomics identifies constitutive activation of the mTORC2/Akt and NF-κB pathways and expressions of IGF-1R, Sirt1, COX-2, and FASN in peripheral T-cell lymphomas: pathogenetic implications and therapeutic options.
    Quesada AE; Nguyen ND; Rios A; Brown RE
    Int J Clin Exp Pathol; 2014; 7(12):8732-9. PubMed ID: 25674239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternative splicing modulates autoinhibition and SH3 accessibility in the Src kinase Fyn.
    Brignatz C; Paronetto MP; Opi S; Cappellari M; Audebert S; Feuillet V; Bismuth G; Roche S; Arold ST; Sette C; Collette Y
    Mol Cell Biol; 2009 Dec; 29(24):6438-48. PubMed ID: 19805512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.